ILROG Team

[ASTRO @ASTRO_org]

Read in the #RedJournal: For the 1st time, consolidation ISRT was randomly compared to IFRT in a phase III trial. Authors argue ISRT/INRT is safe and should thus remain the current standard of care in the setting of CMT of early stage Hodgkin lymphoma. https://t.co/r0Zw4vSUog

[ILROG Team @ILROGTeam]

Congratulations to our colleague and friend, #ILROG Steering Committee member @umbertoricardi on his #klassbreuraward at @ESTRO_RT this year! So deserved! #lymsm

[George Mikhaeel @GeorgeMikhaeel]

Should we extend breast cancer screening to Hodgkin Lymphoma patients treated with chemo only?? #radonc #lymphoma @ILROGTeam @becshakir @DavidJCutter

[Austin Sim, MD JD @A_CT_SimMDJD]

Last hurrah for #ASTRO23 sessions as a Social Champion!
QP 19: Modernizing TBI
First up - @brandon_imber looking at boom boom versus "big boom"
👉 many tx with definitive intent
👉 80% CR - but can take time!
@ILROGTeam

[Austin Sim, MD JD @A_CT_SimMDJD]

@UofT @Mike_Oertel_MD @HoppeBrad Beatrice Fregonese @MSK_RadOnc @ILROGTeam presenting on primary gastric DLBCL
👉 higher RT doses by disease status
👉 no diff PFS/OS by chemo cycles or pre-RT disease status
#ASTRO23

[Austin Sim, MD JD @A_CT_SimMDJD]

Last but not least for the day: #HemeTeam @ASTRO_org/@ILROGTeam myeloma educational session!
👀 come join heme rad oncs with @ILROGTeam in Beijing!
#ASTRO23

[Austin Sim, MD JD @A_CT_SimMDJD]

@PennyFangMD When to consider surgery?
@ILROGTeam steering committee survey for dose in bone + extramedullary
#ASTRO23

[Bradford Hoppe @HoppeBrad]

Another ⁦@ASTRO_org⁩ #ASTRO23 means another CART related RT oral by ⁦@OmranSaifi⁩ Great Job ⁦@MayoFL_RORes⁩ @MayoRadOnc⁩ is proud!!

[Austin Sim, MD JD @A_CT_SimMDJD]

@ILROGTeam Fantastic use of advanced planning and excellent results without auto, with all G3/4 tox during induction.
This ain't your grandparent's mantle RT - highly effective with negligble toxicity!
Maybe we should look at transplant-free survival as a new endpoint? 🧐🤔 #ASTRO23

[Austin Sim, MD JD @A_CT_SimMDJD]

@ILROGTeam Although BV-Nivo did the heavy lifting to CMR, reinforces the benefit of the rational integration of modern RT into evolving systemic therapy paradigms. With the support of groups like @ILROGTeam we can partner with our #HemeTeam colleagues #ASTRO23 @ASH_hematology

[Austin Sim, MD JD @A_CT_SimMDJD]

👉 @ILROGTeam mini atlas is a fantastic resource for involved site rather than involved field
👉NLPHL behaved more like NHL
👉IMRT planning considerations
👉48 second maliginancies/471 patients #ASTRO23

[Austin Sim, MD JD @A_CT_SimMDJD]

A little late, but made it to the @ASTRO_org @ILROGTeam joint session on challenging lymphoma cases! First up: challenging cases in abdominal/pelvic lymphomas with Dr. John Plastaras @PennRadOnc #ASTRO23

[Austin Sim, MD JD @A_CT_SimMDJD]

@ILROGTeam How to sim?
👉 Differences in breast position between arms up/down
👉 Benefits of breath hold
👉 Dose trapping when treating mediastinum/axilla - different priorities between men and women

#ASTRO23

[Chelsea C Pinnix MD PhD @ChelseaPinnix]

Lots to learn at the @ASTRO_org & @ILROGTeam joint session. Practical pearls from @MDAndersonNews @BouthainaDabaja on how to simulate/plan axillary &mediastinal cases for ISRT. Limit dose to the lungs, heart & breasts!Arms down to spare the breast in females. DIBH is your friend.

[Austin Sim, MD JD @A_CT_SimMDJD]

@ILROGTeam How to plan these cases?
✅ mostly anterior beams
✅ lung V5 matters (sorry @jryckman3)
✅ dose constraints in the @NCCN
#ASTRO23

[Austin Sim, MD JD @A_CT_SimMDJD]

Fantastic and well attended #ASTRO23 @ASTRO_org @ILROGTeam educational session on challenging lymphoma cases featuring all the #lymsm #RadOnc royalty!

[Chelsea C Pinnix MD PhD @ChelseaPinnix]

Great presentation by @PennRadOnc John Plastaras on the management of challenging cases with RT. @ILROGTeam @ASTRO_org #ASTRO23 @JillGunther @LenaSpecht1

[Chelsea C Pinnix MD PhD @ChelseaPinnix]

Fun, informative & interactive @ILROGTeam & @ASTRO_org session led by @DrDHodgson. @BouthainaDabaja @JillGunther @LenaSpecht1 John Plastaras #ASTRO23

[Austin Sim, MD JD @A_CT_SimMDJD]

@ILROGTeam Shifting to a mediastinal case - "lymphoma is like a balloon without invading"
💡 post chemotherapy! So less concerned with chasing microscopic disease, especially as these masses "retract" superiorly
#ASTRO23

[George Mikhaeel @GeorgeMikhaeel]

AutoSCT no more required for low risk r/r cHL > BV-Nivo salvage? @HoppeBrad presented CheckMate 774 in #ASTRO2023 with 95% 3yPFS > RT consolidation with no AutoSCT in 28pts 5-30 ys. @ILROGTeam #radonc #hodgkin